Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.
about
Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxisAssessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)-study protocol for a 2×2 factorial randomized trial.Exclusion Criteria in National Health State Valuation Studies: A Systematic Review.EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart reviewHealth problems are more common, but less severe when measured using newer EQ-5D versions.Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic ModuleValidation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging TrialComparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.Expanding Paramedicine in the Community (EPIC): study protocol for a randomized controlled trial.Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.Agreement between Patient and Proxy Assessments of Quality of Life among Older Adults with Vascular Cognitive Impairment Using the EQ-5D-3L and ICECAP-OProtocol of the impact of alternative social assistance disbursement on drug-related harm (TASA) study: a randomized controlled trial to evaluate changes to payment timing and frequency among people who use illicit drugs.Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study.A Time Trade-off-derived Value Set of the EQ-5D-5L for CanadaImpact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancerRelationship between hyperbaric oxygen therapy and quality of life in participants with chronic diabetic foot ulcers: data from a randomized controlled trial.The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis RegistryTime to tweak the TTO: results from a comparison of alternative specifications of the TTO.Time trade-off: one methodology, different methodsThe Role of Preference on Outcomes of People Receiving Evidence-Informed Community Wound Care in Their Home or in a Nurse-Clinic Setting: A Cohort Study (n = 230).A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.Advancing Interprofessional Primary Health Care Services in Rural Settings for People with Chronic Low Back Disorders: Protocol of a Community-Based Randomized Controlled Trial.Economic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial.Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size.Are the EQ-5D-3L and the ICECAP-O responsive among older adults with impaired mobility? Evidence from the Vancouver Falls Prevention Cohort Study.Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L).Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study.Deriving time discounting correction factors for TTO tariffs.Patient-reported outcomes and surgical triage: A gap in patient-centered care?Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States: A Study in the Brazilian Population.Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada.Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada.Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.Using a personalized measure (Patient Generated Index (PGI)) to identify what matters to people with cancer.The added effect of comorbidity on health-related quality of life in patients with asthma.Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder
P2860
Q26865814-BA08C879-BC2E-4073-B960-9A4588C6682CQ27301465-676D8607-9243-410D-82F9-2E99C134E759Q30252110-F4F83DEF-59C6-4279-9A69-AAF974E2C49FQ31124402-E832AC10-2305-42F6-82AB-A4924D7C68B1Q33461841-9AEB0519-0B2D-4197-B464-3505EE185DF0Q33881249-3BD1E91B-2E0C-463B-9AF2-E78056F867E3Q34334025-6CE1DAD9-FD61-4BAC-BD2D-F4FB969C4C6BQ34423176-304DAD53-01D4-47C5-A44E-68455CF5B4CDQ34432229-B294ECEB-6D8C-4790-91A1-E9EE61B7EAB7Q34633630-4F73BB3B-2D33-40C3-A7E1-4A1EC3CDB121Q34897690-A66AF0BB-5D0F-468C-A9BF-A0E5B50D9EA7Q35923254-0DE5950F-7A47-416D-8646-CC836B6968EAQ35996331-F531B918-DF94-4984-A4E7-5E112F2DE8E7Q36090208-0F1D4C04-F0CE-4BDB-A9CA-361EFFF48146Q36322941-DEBAD3D7-BCC4-4C59-91B3-978AF7866B61Q36358903-49FED3B9-3402-4B97-BF73-EBDEC89548FBQ36394607-247029F5-F737-4EE2-B3EA-0772059D6498Q36398877-2087CD85-3D1E-4434-9482-BBCAE42DE4BEQ36996745-CD1C5F32-A1D1-4F82-92A6-E6981E1DE0B9Q37057586-59192985-BD50-4215-AB75-F84DD4E82F94Q37057629-9671A876-3F25-4F2A-943F-988E7C3A4098Q37069497-72713C35-50F8-4803-A508-923AA5544BE2Q37108382-BCEB1C4F-AB37-4CA3-AF09-F8556E1B7049Q37434830-EF7AC2CC-906D-406C-9E6A-7593CD588BC0Q37728309-055DE9A2-9701-441E-A2A4-A6C32A11AEFEQ38254034-AAC98FA2-2E69-489F-A6D3-DD61A61596F1Q38617304-F8B2AA93-A87E-4E45-8251-8183861CD868Q38779332-996A097A-3957-4282-BF16-AB16D4332BFDQ38969855-3FF6A36D-377A-4520-8D95-6E3153EE5A4EQ38998193-FC4B4D2A-6603-4B67-AB36-8F0A509117D6Q39438623-B51FBF7B-B91F-40D4-AE22-D8A401DF34B7Q39703724-9E18DD89-076C-4B18-AF58-440712DE39E3Q40306709-6D94C3BC-8B1F-4B05-9674-602A0F0AD0A4Q40374202-B92DD368-1FD3-4643-A93D-42F39E159C47Q40569987-1C0CF4D5-C1B8-408F-BE89-7DF382E69CC2Q40699234-1B68D398-40A5-4E3B-B0F6-ADBB9FD5C423Q40942161-A00C9732-66D1-4CF4-97B5-3A8C54C36DCCQ41650279-C9ABF030-184E-47DA-9771-CFA5DFD89AB9Q41698270-7FC3F67E-2975-4D9B-B06D-B2B55681C46EQ42709317-0F41A423-B235-46B9-ACD3-316F49711E2A
P2860
Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Canadian valuation of EQ-5D he ...... for future valuation studies.
@ast
Canadian valuation of EQ-5D he ...... for future valuation studies.
@en
Canadian valuation of EQ-5D he ...... for future valuation studies.
@nl
type
label
Canadian valuation of EQ-5D he ...... for future valuation studies.
@ast
Canadian valuation of EQ-5D he ...... for future valuation studies.
@en
Canadian valuation of EQ-5D he ...... for future valuation studies.
@nl
prefLabel
Canadian valuation of EQ-5D he ...... for future valuation studies.
@ast
Canadian valuation of EQ-5D he ...... for future valuation studies.
@en
Canadian valuation of EQ-5D he ...... for future valuation studies.
@nl
P2860
P50
P1433
P1476
Canadian valuation of EQ-5D he ...... for future valuation studies.
@en
P2093
Aslam Anis
P2860
P304
P356
10.1371/JOURNAL.PONE.0031115
P407
P577
2012-02-06T00:00:00Z